If you are free on Thursday, October 10th from 10 a.m.-11 a.m. MT, you may wish to attend this free webinar. Based on the description of the session, it is going to be time well spent. Register here.
Join patient partners and thought leaders in an engaging panel discussion on the value of patient and family partnerships. Learn first-hand about what works well for partnering with patients and families, what doesn’t and tips for collaborating on your system transformation and organizational quality improvement initiatives. This webinar features panelists who have a range of collaboration experience, including at organizational, health system and policy maker levels.
In a recent article found in the Globe and Mail, the following was addressed. “One of my friends says she can do a video chat with her doctor, why isn’t this option more widely available?” If, like many others, you are wondering the same thing, you may wish to read the article here.
“Not my loved ones,” you might be thinking, and I hope you’re right. It’s certainly easier to believe, as I once did, that the opioid crisis is some far-off threat, like a flood or fire in another province. The reality is that it may be bigger and closer than many of us want to admit. (Excerpt from a cbc.ca opinion piece written by Katherine Steinhoff.)
As you may be aware, more and more residents from the US are purchasing their prescription drugs from Canada, due to the lower prices. While this is increasing sales for pharmaceutical companies and their associates, there is a something more important that must be considered. Namely, what effect are the sales of Canadian medicine to our US neighbours having on Canada and we Canadians?
According to a number of professional groups, the outcome of these prescription sales may result in drug shortages Canada. This, in turn, can have negative repercussions on the healthcare of Canadians. As a letter sent by groups representing patients, health professionals, hospitals, and pharmacists to Health Minister Ginette Petitpas Taylor states, “‘The Canadian medicine supply is not sufficient to support both Canadian and U.S. consumers…The supply simply does not, and will not, exist within Canada to meet such demands.”of the potential for increasing drug shortages.'” Read more about thishere.
Are you a patient, family caregiver or healthcare provider who has experience with colorectal cancer? If so, why not share your ideas about NEW research that is needed to improve the lives of those living with and beyond a diagnosis of stage I-III colorectal cancer.
Who is eligible?
1. Stage I-III colorectal cancer patients.
2. Family members to patients diagnosed with state I-III colorectal cancer.
3. Healthcare providers who work with stage I-III colorectal cancer patients.
4. Community or support organization who works with state I-III colorectal cancer patients.
To participate, please visit the following website